In certain studies, the KIAA1549:BRAF fusion gene was also found to function through MEK-dependent activation of both MAPK and mTOR pathways and the injection of neural stem cells containing the fusion were sufficient to induce glioma-like lesions in mice (29). This evidence concerns the gene KIAA1549 and central nervous system cancer.